AiCure

Articles Published in 2008

Phase Forward Acquires IRT Provider Clarix

Monday, September 8, 2008 01:00 PM

Waltham, Mass.-based eClinical technology company Phase Forward has acquired Clarix, a privately held provider of Web-integrated interactive response technology (IRT) based in Radnor, Pa., for $40 million in cash.

More... »


U.S. Disease Foundation Investment in Biopharmaceutical Industry Up 20% in 2008

Friday, September 5, 2008 11:00 AM

U.S. disease foundations will invest about $90 million this year in biopharmaceutical companies to fund discovery and development of new drugs and therapies for their corresponding diseases, according to CenterWatch estimates.

More... »


MDS Pharma Profits Sink in 3rd Quarter

Thursday, September 4, 2008 01:33 PM

Canadian life science company MDS, the parent company of King of Prussia, Pa.-based CRO MDS Pharma Services, reduced its fiscal 2008 revenue and profit outlook after reporting lower than expected third-quarter results in its contract research division. The company now expects fiscal 2008 revenue to be in the range of $1.23 billion to $1.25 billion, down from its previous forecast of $1.25 billion to $1.29 billion.

More... »

CenterWatch Monthly August 2008 Issue

Wednesday, September 3, 2008 04:18 PM

Central and Eastern Europe Triples Global Trial Participation

More... »

Report Questions Safety, Ethics of Clinical Trials in India

Tuesday, September 2, 2008 09:00 AM

India’s booming clinical trials business is under scrutiny, following a story in a UK newspaper that set off a flurry of media and regulatory attention.

More... »

Aptuit Founding CEO Resigns

Thursday, August 28, 2008 01:00 PM

Greenwich, Conn.-based Aptuit, a contract research organization (CRO), named Timothy (Tim) C. Tyson, a pharmaceutical industry veteran, as executive chairman and acting CEO, replacing Michael A. Griffith, the company’s founder and CEO since 2005. The company said Griffith resigned to pursue other opportunities.

More... »

RadPharm Appoints new CIO

Wednesday, August 27, 2008 01:00 PM

RadPharm appointed Steven F. Owens to the newly created position of chief information officer. In this role, Owens will provide leadership to IT and development projects that enhance RadPharm’s technical capabilities and business processes. Before joining RadPharm, Owens was senior director of R&D at the Center for Imaging and Innovation.

More... »

Oncology Accounts for Most Registered Clinical Trials, Rheumatology Sees Growth

Tuesday, August 26, 2008 01:00 PM

Oncology accounted for the most registered clinical trials as of Nov. 1, 2007, according to a recent review of U.S. trials data on ClinicalTrials.gov. The analysis, conducted by Nature Reviews, examined two years of data for industry-sponsored phase II through phase IV trials, including trials that were first registered between October 2005 and September 2007. Oncology, central nervous system disorders, cardiology, infectious diseases, endocrinology and respiratory diseases accounted for almost two-thirds of all protocols and more than two-thirds of all sites. Rheumatology saw the highest relative growth in the number of trials, making rheumatoid arthritis the third most common disease for clinical trials.

More... »

Merck Report Could Alter Clinical Trials, Marketing

Monday, August 25, 2008 01:00 PM

A new report criticizing the use of seeding trials to drive pharmaceutical marketing efforts and jump-start sales could have far-reaching implications for pharmaceutical companies, research sites and clinical trials in general.

More... »

CenterWatch Commentary: Experimental Drug Access Wars Continue

Friday, August 22, 2008 09:00 AM

A U.S. District judge Wednesday ordered PTC Therapeutics to supply its experimental drug to 16-year-old Jacob Gunvalson, who has Duchenne muscular dystrophy, a terminal disease for which there is no known cure.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

November 24

Tufts CSDD’s $2.6 billion price tag to develop and bring a new drug to market raises questions, criticisms

Medidata joins GlaxoSmithKline in study to evaluate the impact of wearing mobile devices in clinical trials

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs